App-Quantinova.ai

Risk Stratification for Major Perioperative Morbidities Using Latent Class Analysis in Patients Undergoing Intraabdominal General Surgery

Minjae Kim - American Society of Anesthesiologists (ASA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

Postoperative Anticoagulants are Effective for Deep Venous Thrombosis Prevention in Extra-High Risk Surgical Patients

Hiroshi Yamaguchi - American Society of Anesthesiologists (ASA) , 2015

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fondaparinux sodium

Anticardiolipin antibodies as potential serologic markers of thrombosis risk in IBD patients; a pilot study in referral IBD center

M. Majerovic - European Crohn’s and Colitis Organisation (ECCO) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Complications of IBD in the anti-TNF era: reason for optimism?

G. Fuhler - European Crohn’s and Colitis Organisation (ECCO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Venous thromboembolism with inflammatory bowel disease

O. Daboussi - European Crohn’s and Colitis Organisation (ECCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical features of thrombosis in patients with Crohns disease followed at the Clinical Hospital of the University of Sao Paulo, Brazil

L. Leite Barros - European Crohn’s and Colitis Organisation (ECCO) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Safety and Tolerability of the Novel Therakos Cellex Machine for Extracorporeal Photopheresis in the Treatment of Gvhd in Children

Hemalatha Geetharani Rangarajan - European Group for Blood and Marrow Transplantation (EBMT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Catheter-Related Complications in Acute Myeloid Leukemia Patients After Hematopoietic Stem Cell Transplant

Mohammad O. Khalil - European Group for Blood and Marrow Transplantation (EBMT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Investigation of ADAMTS13 and VWF in the Patients with Thrombotic Complications Following Hematopoietic Stem-Cell Transplantation (HSCT)

Yue Han - European Group for Blood and Marrow Transplantation (EBMT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Retrospective Survey of Hemostatic Complications in 680 Patients Undergoing Hematopoietic Stem-Cell Transplantation (HSCT)

Yue Han - European Group for Blood and Marrow Transplantation (EBMT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Hemostatic Solution

Leukocytosis Post Engraftment Is Associated with Increased Mortality Among Adult Allogeneic Hematopoietic Cell Transplant (HCT) Reciepients

Jason Balls - American Society of Hematology (ASH) , 2012

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mycophenolic acid

Phase I/II Trial of Lenalidomide and High-Dose Melphalan As Preparative Regimen for Relapsed Myeloma

Muzaffar H. Qazilbash - European Group for Blood and Marrow Transplantation (EBMT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Lenalidomide

Sargramostim (GM-CSF) Combined with IV Plerixafor to Mobilize Peripheral Blood Stem Cells (PBSC) from Normal HLA-Matched Allogeneic Sibling Donors

Mark A. Schroeder - European Group for Blood and Marrow Transplantation (EBMT) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Sargramostim

Emberger Syndrome with Concomitant GATA2, NPM1 and FLT3-ITD Mutations in Remission after Allogeneic Stem Cell Transplant

Abhijit Balkrishna Saste - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Ciprofloxacin

Red Blood Cell Transfusions: Tried and True or Something New?

Penny Odem - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Low Molecular Weight Heparin (LMWH) Prophylaxis to Prevent Sinusoidal Obstructive Syndrome (SOS) in Pediatric Hematopoietic Stem Cell Transplant (HSCT) Recipients

Zelda Ghersin - European Group for Blood and Marrow Transplantation (EBMT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

A SINGLE CENTRE REVIEW OF INCIDENCE OF VENOUS THROMBOEMBOLISM (VTE) IN PATIENTS RECEIVING PALLIATIVE CHEMOTHERAPY FOR UPPER GASTROINTESTINAL CANCERS AND THE IMPACT ON OUTCOMES

Jingree Christopher - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

PULMONARY TOXICITY OF ANTICANCER DRUGS

G. Meyer - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Erythropoietin

INTEGRIN BETA-3 GENETIC VARIANTS PREDICT THE RISK OF THROMBO-EMBOLIC EVENTS IN PATIENTS WITH COLORECTAL CANCER

G. Prager - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

A PHASE II STUDY ON COMBINATION OF AXITINIB AND TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR TREATMENT OF INOPERABLE HEPATOCELLULAR CARCINOMA (HCC)

S.L. Chan - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Inlyta

Filters

7277 Abstracts